Baird Medical Investment Holdings (BDMD) Debt to Equity (2023 - 2025)
Baird Medical Investment Holdings has reported Debt to Equity over the past 3 years, most recently at $0.28 for Q4 2025.
- For Q4 2025, Debt to Equity rose 157.06% year-over-year to $0.28; the TTM value through Dec 2025 reached $0.28, up 157.06%, while the annual FY2025 figure was $0.28, 157.06% up from the prior year.
- Debt to Equity for Q4 2025 was $0.28 at Baird Medical Investment Holdings, up from $0.11 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.28 in Q4 2025 and troughed at $0.07 in Q4 2023.
- A 3-year average of $0.15 and a median of $0.11 in 2024 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: surged 59.63% in 2024 and later soared 157.06% in 2025.
- Year by year, Debt to Equity stood at $0.07 in 2023, then skyrocketed by 59.63% to $0.11 in 2024, then soared by 157.06% to $0.28 in 2025.
- Business Quant data shows Debt to Equity for BDMD at $0.28 in Q4 2025, $0.11 in Q4 2024, and $0.07 in Q4 2023.